Skip to content

MANNAGMENT OF FEMALE INFERTILITY BY AYURVEDA

Management Of Female Infertility W.S.R. To Fallopian Tube Blockage With Virechana And Uttarabasti- A Randomized Clinical Trial

Status
Recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/03/008155
Enrollment
30
Registered
2017-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patient with tube blockage

Interventions

Intervention1: GroupA Virechana Karma followed by Uttarabasti Uttarabasti: GroupA Virechana Karma done by Trivruta Avaleha80 to 100 gms and Uttarabasti with Apamaraga KsharaTaila 5ml and Phalkalyan

Sponsors

INSTITUTE FOR POST GRADUATION TEACHING AND RESEARCH IN AYURVEDA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients of childbearing age (20-37yrs) with active marital life of 1 year or more, having complaint of failure to conceive with at least one fallopian Tube blocked diagnosed by H.S.G. 2) Having seminogram within normal limit of male partner.( >20 million/ml)

Exclusion criteria

Exclusion criteria: 1) Patients having age group below 20 years & above 37 years. 2) Patients having any acute PID, hypersensitivity to chemical dye, congenital anomalies of vulva & vagina, uterus, Ca cervix, STD or any debilitating disease like T.B., HIV, VDRL, HBsAg and TORCH positive will be excluded from study. 3) Patients suffering from infertility due to male factor i.e. Azoospermia, Asthanospermia also be excluded.

Design outcomes

Primary

MeasureTime frame
â?¢ To evaluate and compare the efficacy of trial procedure i.e. Virechana and IUUB(Intrauterine Uttarabasti) of Apamarga Kshara Taila and Phalakalyana Ghrita in opening the fallopian tube and promote the conception rate.Timepoint: virechan and uttarabasti-3 month uttarabasti- 2 month

Secondary

MeasureTime frame
â?¢ To evaluate efficacy of Uttarabasti in menstrual pathology i.e. Dysmenorrhoea, Irregular Menses, Oligomenorrhoea.Timepoint: â?¢ To evaluate efficacy of Uttarabasti in menstrual pathology i.e. Dysmenorrhoea, Irregular Menses, Oligomenorrhoea.

Countries

India

Contacts

Public Contactdr s b donga

ipgt and ra

deilaxmipriya@yahoo.com9228198366

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026